SEC Form 4 · accession 0001683168-26-006206
Sunshine Biopharma Inc. · SBFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Natan
Director
Period of report
Aug 7, 2026
Accepted (ET)
Aug 11, 2026 · 4:23 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001402328
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 7, 2026 | A | 58,300 | $0.00 | A | 68,300 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a stock award to the reporting person.